MMRGlobal Investigates Possible Infringement of Company's Patents and Intellectual Property

MMRGlobal Investigates Possible Infringement of Company's Patents and 
Intellectual Property 
LOS ANGELES, CA -- (Marketwire) -- 02/05/13 --  MMRGlobal, Inc.
(OTCQB: MMRF) ("MMR") today announced that it has been brought to the
Company's attention that Governments, both state and federal, in
Australia, through the National E-Health Transition Authority
(NEHTA), appear to be infringing on patents (including Australian
patent numbers 2006202057 and 2008202401) and other Intellectual
Property (collectively, the "MMRIP") issued to,
Inc., a wholly owned subsidiary of MMRGlobal. NEHTA has reportedly
spent an estimated one billion Australian dollars on a Personal
Health Records program which is the subject of the potential
infringement and which appears to broadly incorporate numerous
portions of the MMR IP.  
As part of the Company's effort to protect its patents, on January
31, 2013, MyMedicalRecords, Inc. announced the filing of a complaint
in the United States for patent infringement against Walgreen Co. The
complaint alleges that Walgreens is infringing on MMR's Personal
Health Records patent, specifically U.S. Patent No. 8,301,466, and as
a result, MMR is seeking monetary damages as well as a permanent
injunction. The complaint was filed in the United States District
Court for the Central District of California, case number CV
13-00631, on January 29 and is available on the court's website  
MMRGlobal has an extensive healthcare IT patent portfolio, which
includes seven U.S. patents: Nos. 8,301,466; 8,352,287; 8,352,288;
8,121,855; 8,117,646; 8,117,045; and 8,321,240. The MMR Patent
Portfolio includes nearly 400 claims as well as additional
applications and continuation applications. The patents involve
inventions pertaining to Personal Health Records, Patient Portals and
other Electronic Health Record systems. MMR also has been granted
patents and has other pending applications in countries of commercial
interest including Australia, Singapore, New Zealand, Mexico, Japan,
Canada, Hong Kong, South Korea, Israel, and European nations. 
About MMRGlobal
 MMRGlobal, Inc., through its wholly-owned operating
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Heal
th Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, retail
pharmacies, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using a
variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records and
sharing them with patients in real time through an integrated patient
portal. Through its merger with Favrille, Inc. in January 2009, the
Company acquired intellectual property biotech assets that include
anti-CD20 antibodies and data and samples from its
FavId(TM)/Specifid(TM) vaccine clinical trials for the treatment of
B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc.
visit View demos and video tutorials of the
Company's products and services at 
Forward-Looking Statements 
  All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property licenses, potential intellectual
property enforcement actions, infringement claims or litigation, and
future performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements."
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the Company's actual
results to be materially different from historical results or from
any results expressed or implied by such forward-looking statements.
Some can be identified by the use of words (and their derivations)
such as "need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes and
results of operations and the timing of selected events may differ
materially from the results predicted, and any reported results
should not be considered as an indication of future performance. Such
statements are necessarily based on assumptions and estimates and are
subject to various risks and uncertainties, including those relating
to the possible invalidity of the underlying assumptions and
estimates and possible changes or developments in economic, business,
industry, market, legal and regulatory circumstances and conditions
and actions taken or omitted to be taken by third parties, including
customers, suppliers, business partners, potential licensees,
competitors and legislative, judicial and other governmental
authorities and officials. Factors that could cause or contribute to
such differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims of
intellectual property infringement and general intellectual property
litigation; our ability to maintain, develop, monetize and protect
our patent portfolio for both the Company's health IT and
biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection with
licensing our intellectual property; our ability to establish and
maintain strategic relationships; changes in our relationships with
our licensees; the risk the Company's products are not adopted or
viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and volume of sales and installations; the
length of sales cycles and the installation process; the market's
acceptance of new product and service introductions; competitive
product offerings and promotions; changes in government laws and
regulations including the 2009 HITECH Act and changes in Meaningful
Use and the 2010 Affordable Care Act; future changes in tax
legislation and initiatives in the healthcare industry; undetected
errors in our products; the possibility of interruption at our data
centers; risks related to third party vendors; risks related to
obtaining and integrating third-party licensed technology; risks
related to a security breach by third parties; risks associated with
recruitment and retention of key personnel; other litigation matters;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in the
Company's filings with the Securities and Exchange Commission.
Additionally there can be no assurance that an infringement of the
Company's intellectual property rights occurred in
 Australia and,
even if such infringement did occur, there can be no assurance that
the Company will be able to prove the infringement or receive damages
in connection with such infringement. The Company is providing this
information as of the date of this release and, except as required by
applicable law, does not undertake any obligation to update any
forward-looking statements contained in this release as a result of
new information, future events or otherwise. 
Michael Selsman
Public Communications Co.
(310) 922-7033 
Press spacebar to pause and continue. Press esc to stop.